Optimal measurement technology – 

uncompromising quality

VEGA - a world class measurement technology provider of level and pressure equipments now completes its measurement portfolio for pharmaceuticals production with two new compact instrument series. VEGABAR and VEGAPOINT proves that automation can be simple and highly efficient without compromising on reliability, hygiene and accuracy. 

VEGABAR 38 is a universal pressure transmitter with ceramic measuring cell for measuring gases, vapours and liquids. The optional universal connection for hygienic adapters ensures reduced installation effort and leaner stock keeping. The sensor has a display with on-site operation and coloured 360° switching status indication.

  • High plant availability through maximum overload and vacuum resistance of the ceramic measuring cell
  • Coloured 360° switching status display, display and on-site operation with VDMA menu structure
  • Easy integration into control systems through IO - Link communication

www.vega.com

VEGAPOINT 21 is a low-cost limit switch for the detection of water-based liquids. The optional universal connection for hygiene adapters ensures reduced installation effort and leaner stock keeping and perfectly meets the requirements for hygienic processes in the food, beverage and pharmaceutical industries. It can be used without adjustment in the application. With IO-Link, it offers continuous digital data transmission.

  • Coloured 360° switching status display, adjustable
  • Easy integration into control systems through IO-Link communication
  • Low-cost limit switch with smallest installation dimensions

No incompatibilities

  • VEGA sensors have been specially developed for the needs of the pharmaceutical industry, which are fulfilled by securely protected sealing, all-metal housings and wetted parts with a surface finish as fine as 0.3 µm RA.

Good manufacturing practice

  • Continuous monitoring of all production processes as well as routine inspection and testing of our sensors make us a reliable partner in adhering to good manufacturing practice. The basis for this is our quality management in compliance with ISO 9001 and our environmental management program based on ISO 14001.

Easy cleaning – reliable processes

  • To help ensure hygienic and sterile drug production processes, VEGA offers materials specially tailored to the strict requirements of the pharmaceutical industry – with all necessary approvals and material properties.

VEGA Australia Pty Ltd
Phone: +61 2 95426662
Email: info.au@vega.com

www.vega.com

Go to article: Home | Under the microscopeGo to article: In this issueGo to article: SHL Medical Company InsightGo to article: SHL MedicalGo to article: ContentsGo to article: MimotopesGo to article: NewsGo to article: VEGA AustraliaGo to article: Covid-19 executive briefing by GlobalDataGo to article: WipotecGo to article: Nasal spray vaccine for Covid-19Go to article: Datwyler Company Insight Go to article: DatwylerGo to article: Covid-19 clinical trials continue to rise in BrazilGo to article: BiogazelleGo to article: AstraZeneca’s Phase I / II Covid-19 vaccine trial Go to article: SwiftpakGo to article: MTPA resumes screening and enrolment for global Phase III clinical trial of MT-1Go to article: Biesterfeld Go to article: The pharma industry briefingGo to article: From antitoxins to Covid-19 drugs: charting the history of antibody drugsGo to article: Quality control: pharma manufacturing inspections explainedGo to article: Molnár-Institute Company InsightGo to article: Molnar-InstituteGo to article: Oxytocin: the therapeutic potential of the ‘love hormone’Go to article: AI-enabled risk detection in pharma manufacturingGo to article: Dr. Paul LohmannGo to article: Addressing the long-term effects of Covid-19Go to article: Eyes on the prize: the latest in retinitis pigmentosa gene therapiesGo to article: HOF Sonderanlagenbau Company Insight Go to article: HOF SonderanlagenbauGo to article: Breaking the taboo: disrupting the fertility sectorGo to article: Neutralising the gluten threat: are we on the cusp of a coeliac disease breakthrough? Go to article: Nolato Company Insight Go to article: NolatoGo to article: Pharmacovigilance case intake: why the hesitation to automate?Go to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: Zenatek Go to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: EventsGo to article: Next issue